SEC Form D · filed March 1, 2023
Chroma Medicine, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
George Golumbeski · BOSTON, MADirectorJeff Marrazzo · BOSTON, MADirectorThomas Cahill · BOSTON, MADirectorBihua Chen · BOSTON, MADirectorKevin Bitterman · BOSTON, MADirectorVic Myer · BOSTON, MAExecBrett Kaplan · BOSTON, MAExecPaola Pozzi · BOSTON, MADirectorMichael Kelly · BOSTON, MADirectorCatherine Stehman-Breen · BOSTON, MAExec · DirectorRobin Wilson · St. Helier, Y9DirectorNicola Harte · St. Helier, Y9DirectorLewis Fellas · St. Helier, Y9Exec · DirectorJonathan S. Spencer · New York, NYDirectorFloretta Gogo · Atlanta, GAExecTIG Opportunity Partners, LLC · New York, NYDirectorJamie Brown · Atlanta, GAExecJordan Balencic · Atlanta, GADirectorDale J. Dobson · Vancouver, British Columbia, CanadaDirectorXavier Carter · Atlanta, GADirectorChris Catalano · Bellmore, NYExecJames Mulvihill · Golden, COExecLiad Meidar · Seattle, WADirectorBrad Harlow · Seattle, WADirectorJamie Brodsky · Port Washington, NYDirectorAmy Springs · Port Washington, NYDirectorDaniel Flannery · Port Washington, NYExec · DirectorChristopher Abbate · Port Washington, NYDirectorRobert C. Manzino · New York, NYDirectorDaniel Calvo · Beverly, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗